Controversial stem-cell company moves treatment out of the United States

| February 1, 2013 |

The following is an excerpt.

US citizens who had pinned their hopes on a company being able to offer stem-cell treatments close to home will now need to travel a little farther. Celltex Therapeutics of Houston, Texas, stopped treating patients in the United States last year following a warning from regulators. A 25 January e-mail to Celltex customers indicates that the firm will now follow in the footsteps of many other companies offering unproven stem-cell therapies and send its patients abroad for treatment — but only to Mexico.

Read the full article here: Controversial stem-cell company moves treatment out of the United States